| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H21N3OS |
| Molecular Weight | 291.412 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(CN(CCN(C)C)C2=NC=CS2)C=C1
InChI
InChIKey=KYBJXENQEZJILU-UHFFFAOYSA-N
InChI=1S/C15H21N3OS/c1-17(2)9-10-18(15-16-8-11-20-15)12-13-4-6-14(19-3)7-5-13/h4-8,11H,9-10,12H2,1-3H3
| Molecular Formula | C15H21N3OS |
| Molecular Weight | 291.412 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Sourcing
PubMed
Patents
Sample Use Guides
Eight female pigs were anaesthetized byinitially intramuscular injection of a 1 ml mixture con-sisting of zolamine 5 mg/ml, butorphanol 1 mg/ml,ketamine 10 mg/ml and xylazin 2 mg/ml, followedby continuous intravenous infusion of propofol10 mg/kg per hour and fentanyl 0.025 mg/kg perhour throughout the operation.
Route of Administration:
Intramuscular
